)
Shares of Bliss GVS Pharma are locked at the upper circuit of 20% at Rs 158, also their 52-week highs on the NSE, after the company announced that it had bagged a $35 million (approximately Rs 220 crore) contract for providing medical healthcare services in Kenya.
The Teachers Services Commission has awarded Bliss GVS Healthcare, the Kenyan step-down subsidiary of Bliss GVS Pharma, in association with Aon Kenya Insurance Brokers, an annual service contract worth $350 million to provide medical healthcare cover, the company said in a statement.
The contract is effective from 1st July 2015 and the first quarterly payment has been received by the company.
Besides the said services, the contract also envisages supplies of various Bliss GVS Pharma products from India, for administering to patients covered under this scheme.
The trading volumes on the counter jumped more than three-fold. Till 1034 hours, a combined 2.41 million shares changed hands on the counter and there were pending buy orders for 1.59 million shares on the BSE and NSE.
The Teachers Services Commission has awarded Bliss GVS Healthcare, the Kenyan step-down subsidiary of Bliss GVS Pharma, in association with Aon Kenya Insurance Brokers, an annual service contract worth $350 million to provide medical healthcare cover, the company said in a statement.
The contract is effective from 1st July 2015 and the first quarterly payment has been received by the company.
Besides the said services, the contract also envisages supplies of various Bliss GVS Pharma products from India, for administering to patients covered under this scheme.
The trading volumes on the counter jumped more than three-fold. Till 1034 hours, a combined 2.41 million shares changed hands on the counter and there were pending buy orders for 1.59 million shares on the BSE and NSE.
